NOT-DE-22-014: Notice of NIDCR Participation in RFA-CA-22-040, The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)

Notice of NIDCR Participation in RFA-CA-22-040, “The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)”

Notice Number:

NOT-DE-22-014

Key Dates

Release Date:

July 27, 2022

Related Announcements

RFA-CA-22-040 - The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)

Issued by

National Institute of Dental and Craniofacial Research (NIDCR)

Purpose

This purpose of this Notice is to inform potential applicants that the National Institute of Dental and Craniofacial Research (NIDCR) is participating, effective immediately, in Funding Opportunity Announcement (FOA) RFA-CA-22-040, “The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)”.

The following sections of RFA-CA-22-040 have been modified (shown in italics) to reflect NIDCR's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)

National Institute of Dental and Craniofacial Research (NIDCR)

Assistance Listing Number(s)

93.394, 93.121

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Zhong Chen, MD, PhD
National Institute of Dental and Craniofacial Research
Tel: 301-529-7083
Email: [email protected]